Featured Research

from universities, journals, and other organizations

Producing Medicines In Plant Seeds

Date:

January 16, 2007

Source:

VIB, Flanders Interuniversity Institute of Biotechnology

Summary:

Using plants to produce useful proteins could be an inexpensive alternative to current medicine production methods. Researchers from VIB at Ghent University have succeeded in producing in plant seeds proteins that have a very strong resemblance to antibodies. They have also demonstrated that these antibody variants are just as active as the whole antibodies that occur naturally in humans. By virtue of their particular action, antibodies are very useful for therapeutic and diagnostic applications.

Share This

Using plants to produce useful proteins could be an inexpensive alternative to current medicine production methods. Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) at Ghent University have succeeded in producing in plant seeds proteins that have a very strong resemblance to antibodies. They have also demonstrated that these antibody variants are just as active as the whole antibodies that occur naturally in humans.

Related Articles

By virtue of their particular action, antibodies are very useful for therapeutic and diagnostic applications. From this research, it is now also clear that these kinds of antibody variants can be used in medical applications and that it is possible to produce them in the seeds of plants, which can have enormous advantages over conventional production methods.

Production of biotech medicines

A large number of today's medicines are made with the aid of biotechnology (and this number should only grow in the future). To do this, scientists use genetically modified bacteria, yeasts, or animal cells that are able to produce human proteins. These proteins are then purified and administered as medicines. Examples of such proteins are antibodies, which can be used, for instance, in the treatment of cancer. The conventional methods for producing antibodies work well, but they are expensive and have a limited production capacity. The high costs are primarily due to the need for well-equipped production labs and to the labor-intensive upkeep of the animal cells, which are needed as production units.

Plants: a possible alternative?

For a number of years now, the VIB researchers in Ghent - Bart Van Droogenbroeck, Ann Depicker and Geert De Jaeger- have been searching for ways to have plants produce useful proteins efficiently. Plants do offer a lot of advantages over conventional production methods. Because production with plants doesn't require expensive high-tech laboratories, scientists anticipate that, by working with plants, production costs will be 10 to 100 times lower. Another important advantage is that large-scale production is possible without having to make additional investments in expensive fermentors.

A good yield guaranteed

Several years ago, Geert De Jaeger and his colleagues succeeded in achieving a high yield of an antibody variant in plants, which had been very difficult to do up to that time. The trick the researchers used was to modify the plants in such a way that they would produce the antibody variant in their seeds. With their special technique, the scientists succeeded in producing seeds in which the desired protein is good for more than one third of the total protein amount. This is a huge proportion compared to other systems - normally, scientists succeed in replacing only 1% of the plant's proteins by the desired protein.

Plant seeds are especially attractive as production units. In addition to a high production capacity, they offer other important advantages over other parts of the plant. The seeds can be stored for a long time without losing the produced protein's effectiveness, so that a reserve can always be kept on hand. This means that the proteins can be isolated from the seeds at the moment that they are actually needed. With production in leaves, for example - or with conventional production methods - such lengthy storage is not possible: the protein must be isolated immediately after production. So, production in plant seeds provides the clear advantage of timely processing.

High production of an efficient antibody variant

The antibody variant that has been produced by Geert De Jaeger and his team has a very simple structure and has only one binding place for a particular substance. Bart Van Droogenbroeck and his colleagues, under the direction of Ann Depicker, are now showing that it is also possible to produce more complex antibody variants in large quantities in the seeds of the Arabidopsis plant. Over 10% of the proteins in the seeds of these plants are the desired antibody variant. As is the case with whole antibodies, these more complex antibody variants have two binding places for a specified substance. This close similarity to whole antibodies makes these antibody variants extremely useful for therapeutic and diagnostic applications.

However, the production of proteins in plants is completed in a different way than in humans. Therefore, to be certain that this different completion process does not affect the effectiveness of the potential medicine; the scientists have subjected the action of the antibody variant to an exhaustive battery of tests. These laboratory tests have shown that the antibody variants produced in plants are just as effective as whole human antibodies in protecting animal cells against infection with the Hepatitis A virus.

This is a significant step forward in making protein production in plants a real alternative to current production methods.

More From ScienceDaily

More Plants & Animals News

Featured Research

Mar. 31, 2015 — Researchers have recorded the first direct observations of the micro-scale mechanisms behind the ability of skin to resist tearing. The results could be applied to the improvement of artificial skin, ... full story

Mar. 31, 2015 — Soil organic matter, long thought to be a semi-permanent storehouse for ancient carbon, may be much more vulnerable to climate change than previously thought. Scientists have found that the common ... full story

Mar. 31, 2015 — Using the assessment tool ForWarn, US Forest Service researchers can monitor the growth and development of vegetation that signals winter's end and the awakening of a new growing season. Now these ... full story

Mar. 31, 2015 — Until now electric fences and trenches have proved to be the most effective way of protecting farms and villages from night time raids by hungry elephants. But researchers think they may have come up ... full story

Mar. 31, 2015 — The endangered desert pupfish has made itself at home in the harsh, hot environment of Death Valley hot springs by using a surprising evolutionary adaptation: They can go for up to five hours without ... full story

Mar. 31, 2015 — Researchers have detected a human fingerprint deep in the Borneo rainforest in Southeast Asia. Cold winds blowing from the north carry industrial pollutants from East Asia to the equator, with ... full story

Mar. 31, 2015 — A team of engineers and biologists reports new progress in using computer modeling and 3D shape analysis to understand how the unique grasping tails of seahorses evolved. These prehensile tails ... full story

Mar. 31, 2015 — As the five-year anniversary of the explosion of the Deepwater Horizon oil rig approaches, a new report looks at how twenty species of wildlife are faring in the aftermath of the ... full story

Mar. 31, 2015 — Scientists have uncovered the earliest fossilized evidence of an insect caring for its young. The findings push back the earliest direct evidence of insect brood care by more than 50 million years, ... full story

Giant Amphibian Fossils Found in Portugal

Reuters - Light News Video Online (Mar. 31, 2015) — Scientists discover a new species of giant amphibian that was one of the largest predators on earth about 220 million year ago. Tara Cleary reports.
Video provided by Reuters

Bionic Ants Could Be Tomorrow's Factory Workers

Reuters - Innovations Video Online (Mar. 30, 2015) — Industrious 3D printed bionic ants working together could toil in the factories of the future, says German technology company Festo. The robotic insects cooperate and coordinate their actions and movements to achieve a common aim. Amy Pollock reports.
Video provided by Reuters

Related Stories

Apr. 2, 2013 — For the first time, researchers were able to stimulate immune cells to produce broadly neutralizing antibodies: a critical step that has eluded researchers for decades but that provides promise for a ... full story

Feb. 1, 2013 — Smoking tobacco is bad for your health, but a genetically altered version of the plant might provide an inexpensive cure for the deadly rabies virus. Scientists have produced a monoclonal antibody in ... full story

May 26, 2011 — Some people think of herbal teas, others of tobacco when they hear the buzzword 'medicines from plants'. One research team succeeded in producing biopharmaceuticals -- such as an antibody ... full story

Oct. 5, 2010 — Therapeutic antibodies can be an efficient alternative when common drugs do not work anymore. However, antibodies obtained from blood of animals such as mice could not be used: The human immune ... full story

Apr. 1, 2010 — Scientists have discovered how plants turn their defense mechanisms on and off. The system is apparently controlled by a key protein that the researchers have named "NINJA." The discovery ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.